Increased perfusion in normal appearing white matter in high inflammatory multiple sclerosis patients

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Bester, Maxim ^a   Forkert, Nils Daniel ^a,b   Stellmann, Jan Patrick ^a   Aly, Lilian ^c   Drabik, Anna ^a   Young, Kim Lea ^a   Heesen, Christoph ^a   Fiehler, Jens ^a   Siemonsen, Susanne ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY OF CALGARY   (Canada)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GADOTERATE MEGLUMINE;

ADULT; ARTICLE; BLOOD BRAIN BARRIER; BRAIN ATROPHY; BRAIN BLOOD FLOW; BRAIN BLOOD VOLUME; BRAIN MICROCIRCULATION; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DISEASE ASSOCIATION; FEMALE; HUMAN; MALE; MEMBRANE DAMAGE; MIDDLE AGED; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PATHOPHYSIOLOGY; PERFUSION WEIGHTED IMAGING; SUSCEPTIBILITY WEIGHTED IMAGING; THREE DIMENSIONAL IMAGING; WHITE MATTER; YOUNG ADULT; BRAIN CIRCULATION; INFLAMMATION; MAGNETIC RESONANCE ANGIOGRAPHY; PROSPECTIVE STUDY; VASCULARIZATION;

ADULT; CEREBROVASCULAR CIRCULATION; FEMALE; HUMANS; INFLAMMATION; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; PROSPECTIVE STUDIES; WHITE MATTER; YOUNG ADULT;

EID: 84924942254     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0119356     Document Type: Article

References (46)

1. Barkhof F. MRI in multiple sclerosis: correlation with expanded disability status scale (EDSS). Mult Scler 1999; 5: 283-286. PMID: 10467389
2. Zeis T, Graumann U, Reynolds R, Schaeren-Wiemers N. Normal-appearing white matter in multiple sclerosis is in a subtle balance between inflammation and neuroprotection. Brain 2008; 131: 288-303. PMID: 18056737
3. Raz E, Cercignani M, Sbardella E, Totaro P, Pozzilli C, et al. Clinically isolated syndrome suggestive of multiple sclerosis: voxelwise regional investigation of white and gray matter. Radiology 2010; 254: 227-234. doi: 10.1148/radiol.2541090817 PMID: 20019140
4. Putnam TJ. The pathogenesis of multiple sclerosis: a possible vascular factor. New England Journal of Medicine 1933
5. Wakefield AJ, More LJ, Difford J, McLaughlin JE. Immunohistochemical study of vascular injury in acute multiple sclerosis. J Clin Pathol 1994; 47: 129-133. PMID: 8132826
6. Adams CW, Poston RN, Buk SJ, Sidhu YS, Vipond H. Inflammatory vasculitis in multiple sclerosis. J Neurol Sci 1985; 69: 269-283. PMID: 4031947
7. Soon D, Tozer DJ, Altmann DR, Tofts PS, Miller DH. Quantification of subtle blood-brain barrier disruption in non-enhancing lesions in multiple sclerosis: a study of disease and lesion subtypes. Mult Scler 2007; 13: 884-894. PMID: 17468443
8. Law M, Saindane AM, Ge Y, Babb JS, Johnson G, et al. Microvascular Abnormality in Relapsing-Remitting Multiple Sclerosis: Perfusion MR Imaging Findings in Normal-appearing White Matter. Radiology 2004; 231: 645-652. PMID: 15163806
9. Adhya S, Johnson G, Herbert J, Jaggi H, Babb JS, et al. Pattern of hemodynamic impairment in multiple sclerosis: Dynamic susceptibility contrast perfusion MR imaging at 3.0 T. Neuroimage 2006; 33: 1029-1035. PMID: 16996280
10. Varga AW, Johnson G, Babb JS, Herbert J, Grossman RI, et al. White matter hemodynamic abnormalities precede sub-cortical gray matter changes in multiple sclerosis. J Neurol Sci 2009; 282: 28-33. doi: 10.1016/j.jns.2008.12.036 PMID: 19181347
11. Rashid W, Parkes LM, Ingle GT, Chard DT, Toosy AT, et al. Abnormalities of cerebral perfusion in multiple sclerosis. J Neurol Neurosurg Psychiatr 2004; 75: 1288-1293. PMID: 15314117
12. Paling D, Thade Petersen E, Tozer DJ, Altmann DR, Wheeler-Kingshott CAM, et al. Cerebral arterial bolus arrival time is prolonged in multiple sclerosis and associated with disability. J Cereb Blood Flow Metab 2014; 34: 34-42. doi: 10.1038/jcbfm.2013.161 PMID: 24045400
13. Wuerfel J, Bellmann-Strobl J, Brunecker P, Aktas O, McFarland H, et al. Changes in cerebral perfusion precede plaque formation in multiple sclerosis: a longitudinal perfusion MRI study. Brain 2004, 127: 111-119. PMID: 14570816
14. Ge Y, Law M, Johnson G, Herbert J, Babb JS, et al. Dynamic susceptibility contrast perfusion MR imaging of multiple sclerosis lesions: characterizing hemodynamic impairment and inflammatory activity. Am J Neuroradiol 2005; 26: 1539-1547. PMID: 15956527
15. Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011; 69: 292-302. doi: 10.1002/ana.22366 PMID: 21387374
16. Giovannoni G, Radue E-W, Havrdova E, Riester K, Greenberg S, et al. Effect of daclizumab high-yield process in patients with highly active relapsing-remitting multiple sclerosis. J Neurol 2014; 261: 316-323. doi: 10.1007/s00415-013-7196-4 PMID: 24375015
17. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33: 1444-1452. PMID: 6685237
18. Smith SM, Zhang Y, Jenkinson M, Chen J, Matthews PM, et al. Accurate, robust, and automated longitudinal and cross-sectional brain change analysis. Neuroimage 2002; 17: 479-489. PMID: 12482100
19. Battaglini M, Jenkinson M, De Stefano N. Evaluating and reducing the impact of white matter lesions on brain volume measurements. Human brain mapping 2012; 33: 2062-2071. doi: 10.1002/hbm.21344 PMID: 21882300
20. Forkert ND, Cheng B, Kemmling A, Thomalla G, Fiehler J. ANTONIA Perfusion and Stroke. A Software Tool for the Multi-purpose Analysis of MR Perfusion-weighted Datasets and Quantitative Ischemic Stroke Assessment. Methods Inf Med 2014; 53(6): 469-481. doi: 10.3414/ME14-01-0007 PMID: 25301390
21. Li X, Tian J, Millard RK. Erroneous and inappropriate use of gamma fits to tracer-dilution curves in magnetic resonance imaging and nuclear medicine. Magn Reson Imaging 2003; 21: 1095-1096. PMID: 14684217
22. Greve DN, Fischl B. Accurate and robust brain image alignment using boundary-based registration. Neuroimage 2009; 48: 63-72. doi: 10.1016/j.neuroimage.2009.06.060 PMID: 19573611
23. Haselhorst RR, Kappos LL, Bilecen DD, Scheffler KK, Möri DD, et al. Dynamic susceptibility contrast MR imaging of plaque development in multiple sclerosis: application of an extended blood-brain barrier leakage correction. Journal of magnetic resonance imaging: JMRI 2000; 11: 495-505. PMID: 10813859
24. Papadaki EZ, Mastorodemos VC, Amanakis EZ, Tsekouras KC, Papadakis AE, et al. White matter and deep gray matter hemodynamic changes in multiple sclerosis patients with clinically isolated syndrome. Magnetic resonance in medicine: official journal of the Society of Magnetic Resonance in Medicine /Society of Magnetic Resonance in Medicine 2012; 68: 1932-1942. doi: 10.1002/mrm.24194 PMID: 22367604
25. Ingrisch MM, Sourbron SS, Morhard DD, Ertl-Wagner BB, Kümpfel TT, et al. Quantification of perfusion and permeability in multiple sclerosis: dynamic contrast-enhanced MRI in 3D at 3T. Investigative radiology 2012; 47: 252-258. doi: 10.1097/RLI.0b013e31823bfc97 PMID: 22373532
26. Banati RB, Newcombe J, Gunn RN, Cagnin A, Turkheimer F, et al. The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity. Brain 2000; 123 (Pt 11): 2321-2337. PMID: 11050032
27. Lucchinetti CF, Parisi J, Bruck W. The pathology of multiple sclerosis. Neurologic clinics 2005; 23: 77-105. PMID: 15661089
28. Haider L, Fischer MT, Frischer JM, Bauer J, Höftberger R, et al. Oxidative damage in multiple sclerosis lesions. Brain 2011; 134: 1914-1924. doi: 10.1093/brain/awr128 PMID: 21653539
29. Hartung T, Sauer A, Wendel A. Testing of immunomodulatory properties in vitro. Dev Biol Stand 1996; 86: 85-96. PMID: 8785996
30. Kostyk SK, Kowall NW, Hauser SL. Substance P immunoreactive astrocytes are present in multiple sclerosis plaques. Brain Res 1989; 504: 284-288. PMID: 2480834
31. Holley JE, Newcombe J, Whatmore JL, Gutowski NJ. Increased blood vessel density and endothelial cell proliferation in multiple sclerosis cerebral white matter. Neurosci Lett 2010; 470: 65-70. doi: 10. 1016/j.neulet.2009.12.059 PMID: 20036712
32. Roscoe WA, Welsh ME, Carter DE, Karlik SJ. VEGF and angiogenesis in acute and chronic MOG((35- 55)) peptide induced EAE. J Neuroimmunol 2009; 209: 6-15. doi: 10.1016/j.jneuroim.2009.01.009 PMID: 19233483
33. Pathak AP, Schmainda KM, Ward BD, Linderman JR, Rebro KJ, et al. MR-derived cerebral blood volume maps: issues regarding histological validation and assessment of tumor angiogenesis. Magnetic resonance in medicine: official journal of the Society of Magnetic Resonance in Medicine 2001; 46: 735-747. PMID: 11590650
34. Jain RK. Tumor angiogenesis and accessibility: role of vascular endothelial growth factor. Semin Oncol 2002; 29: 3-9. PMID: 12584689
35. Inglese M, Park S-J, Johnson G, Babb JS, Miles L, et al. Deep gray matter perfusion in multiple sclerosis: dynamic susceptibility contrast perfusion magnetic resonance imaging at 3 T. Arch Neurol 2007; 64: 196-202. PMID: 17296835
36. Inglese M, Adhya S, Johnson G, Babb JS, Miles L, et al. Perfusion magnetic resonance imaging correlates of neuropsychological impairment in multiple sclerosis. J Cereb Blood Flow Metab 2007; 28: 164-171. PMID: 17473851
37. Filippi M, Rocca MA, Benedict RHB, DeLuca J, Geurts JJG, et al. The contribution of MRI in assessing cognitive impairment in multiple sclerosis. Neurology 2010; 75: 2121-2128. doi: 10.1212/WNL. 0b013e318200d768 PMID: 21135387
38. Law M, Saindane AM, Ge Y, Babb JS, Johnson G, et al. Microvascular Abnormality in Relapsing-Remitting Multiple Sclerosis: Perfusion MR Imaging Findings in Normal-appearing White Matter. Radiology 2004; 231: 645-652. PMID: 15163806
39. Kalman B, Leist TP. A mitochondrial component of neurodegeneration in multiple sclerosis. Neuromolecular Med 2003; 3: 147-158. PMID: 12835510
40. Heales SJ, Bolaños JP, Stewart VC, Brookes PS, Land JM, et al. Nitric oxide, mitochondria and neurological disease. Biochim Biophys Acta 1999; 1410: 215-228. PMID: 10076028
41. Lassmann H. Hypoxia-like tissue injury as a component of multiple sclerosis lesions. J Neurol Sci 2003; 206: 187-191. PMID: 12559509
42. Juurlink BHJ. The evidence for hypoperfusion as a factor in multiple sclerosis lesion development. Mult Scler Int 2013; 2013:598093. doi: 10.1155/2013/598093 PMID: 23691321
43. Khan O, Filippi M, Freedman MS, Barkhof F, Dore-Duffy P, et al. Chronic Cerebrospinal Venous Insufficiency and Multiple Sclerosis. Ann Neurol 2010; 67: 286-290. doi: 10.1002/ana.22001 PMID: 20373339
44. Cramer SP, Simonsen H, Frederiksen JL, Rostrup E, Larsson HBW. Abnormal blood-brain barrier permeability in normal appearing white matter in multiple sclerosis investigated by MRI. Neuroimage Clin 2014; 4: 182-189. doi: 10.1016/j.nicl.2013.12.001 PMID: 24371801
45. Inglese M, Park S-J, Johnson G, Babb JS, Miles L, et al. Deep gray matter perfusion in multiple sclerosis: dynamic susceptibility contrast perfusion magnetic resonance imaging at 3 T. Arch Neurol 2007; 64: 196-202. PMID: 17296835
46. Papadaki EZ, Simos PG, Panou T, Mastorodemos VC, Maris TG, et al. Hemodynamic evidence linking cognitive deficits in clinically isolated syndrome to regional brain inflammation. Eur J Neurol 2014; 21: 499-505. doi: 10.1111/ene.12338 PMID: 24373026